Frontlight ResearchEarly access
Long COVID and ME/CFS trials in Uzbekistan
1 trial · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationLong COVID Diagnostic Reactivity Assesment Test
- Where
- Tashkent
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Oncology Center,Ministry Of Heath,Uzbekistan
See details and how to joinNCT07343856